AZ 21666

Drug Profile

AZ 21666

Alternative Names: ACN 111

Latest Information Update: 29 Oct 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Asahi Kasei
  • Class Antipsychotics
  • Mechanism of Action Opioid receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Schizophrenia

Most Recent Events

  • 29 Oct 2003 Discontinued - Preclinical for Schizophrenia in Japan (unspecified route)
  • 18 Jul 2001 No-Development-Reported for Schizophrenia in Japan (Unknown route)
  • 15 Jan 2001 Asahi Chemical is now called Asahi Kasei
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top